W. Staub

Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC.

For over a decade, Novella Clinical has been an active partner in supporting the biopharma and medical device industries with early phase through post-marketing development programs. Although their clinical experience is all-inclusive, the company's eClinical roots enable them to offer services that are specific to their clients' needs, often eliminating the demand to contract with multiple partners. From protocol development through final clinical study report - they integrate deep clinical expertise with industry-leading technologies and a proven approach to support, streamline and expertly resource the entire product development process. It focuses on quality customer service is reflected in their certification by Underwriters Laboratories on meeting global quality standards (ISO 9001:2008).

Zeneca Pharmaceuticals manufactures medicines.

For over a decade, Novella Clinical has been an active partner in supporting the biopharma and medical device industries with early phase through post-marketing development programs. Although their clinical experience is all-inclusive, the company's eClinical roots enable them to offer services that are specific to their clients' needs, often eliminating the demand to contract with multiple partners. From protocol development through final clinical study report - they integrate deep clinical expertise with industry-leading technologies and a proven approach to support, streamline and expertly resource the entire product development process. It focuses on quality customer service is reflected in their certification by Underwriters Laboratories on meeting global quality standards (ISO 9001:2008).

Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC.

Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC.

Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina.

Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC.

For over a decade, Novella Clinical has been an active partner in supporting the biopharma and medical device industries with early phase through post-marketing development programs. Although their clinical experience is all-inclusive, the company's eClinical roots enable them to offer services that are specific to their clients' needs, often eliminating the demand to contract with multiple partners. From protocol development through final clinical study report - they integrate deep clinical expertise with industry-leading technologies and a proven approach to support, streamline and expertly resource the entire product development process. It focuses on quality customer service is reflected in their certification by Underwriters Laboratories on meeting global quality standards (ISO 9001:2008).

For over a decade, Novella Clinical has been an active partner in supporting the biopharma and medical device industries with early phase through post-marketing development programs. Although their clinical experience is all-inclusive, the company's eClinical roots enable them to offer services that are specific to their clients' needs, often eliminating the demand to contract with multiple partners. From protocol development through final clinical study report - they integrate deep clinical expertise with industry-leading technologies and a proven approach to support, streamline and expertly resource the entire product development process. It focuses on quality customer service is reflected in their certification by Underwriters Laboratories on meeting global quality standards (ISO 9001:2008).

For over a decade, Novella Clinical has been an active partner in supporting the biopharma and medical device industries with early phase through post-marketing development programs. Although their clinical experience is all-inclusive, the company's eClinical roots enable them to offer services that are specific to their clients' needs, often eliminating the demand to contract with multiple partners. From protocol development through final clinical study report - they integrate deep clinical expertise with industry-leading technologies and a proven approach to support, streamline and expertly resource the entire product development process. It focuses on quality customer service is reflected in their certification by Underwriters Laboratories on meeting global quality standards (ISO 9001:2008).

For over a decade, Novella Clinical has been an active partner in supporting the biopharma and medical device industries with early phase through post-marketing development programs. Although their clinical experience is all-inclusive, the company's eClinical roots enable them to offer services that are specific to their clients' needs, often eliminating the demand to contract with multiple partners. From protocol development through final clinical study report - they integrate deep clinical expertise with industry-leading technologies and a proven approach to support, streamline and expertly resource the entire product development process. It focuses on quality customer service is reflected in their certification by Underwriters Laboratories on meeting global quality standards (ISO 9001:2008).

For over a decade, Novella Clinical has been an active partner in supporting the biopharma and medical device industries with early phase through post-marketing development programs. Although their clinical experience is all-inclusive, the company's eClinical roots enable them to offer services that are specific to their clients' needs, often eliminating the demand to contract with multiple partners. From protocol development through final clinical study report - they integrate deep clinical expertise with industry-leading technologies and a proven approach to support, streamline and expertly resource the entire product development process. It focuses on quality customer service is reflected in their certification by Underwriters Laboratories on meeting global quality standards (ISO 9001:2008).

For over a decade, Novella Clinical has been an active partner in supporting the biopharma and medical device industries with early phase through post-marketing development programs. Although their clinical experience is all-inclusive, the company's eClinical roots enable them to offer services that are specific to their clients' needs, often eliminating the demand to contract with multiple partners. From protocol development through final clinical study report - they integrate deep clinical expertise with industry-leading technologies and a proven approach to support, streamline and expertly resource the entire product development process. It focuses on quality customer service is reflected in their certification by Underwriters Laboratories on meeting global quality standards (ISO 9001:2008).

For over a decade, Novella Clinical has been an active partner in supporting the biopharma and medical device industries with early phase through post-marketing development programs. Although their clinical experience is all-inclusive, the company's eClinical roots enable them to offer services that are specific to their clients' needs, often eliminating the demand to contract with multiple partners. From protocol development through final clinical study report - they integrate deep clinical expertise with industry-leading technologies and a proven approach to support, streamline and expertly resource the entire product development process. It focuses on quality customer service is reflected in their certification by Underwriters Laboratories on meeting global quality standards (ISO 9001:2008).

Zeneca Pharmaceuticals manufactures medicines.

Zeneca Pharmaceuticals manufactures medicines.

Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC.

Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC.

Zeneca Pharmaceuticals manufactures medicines.

Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC.

Zeneca Pharmaceuticals manufactures medicines.